PAQR8 is a plasma membrane progesterone receptor coupled to G-protein signaling pathways, specifically operating through G(i)-mediated mechanisms 1. Beyond progesterone binding, PAQR8 recognizes multiple neuroactive steroids including dehydroepiandrosterone, pregnanolone, pregnenolone, and allopregnanolone 2. The receptor appears involved in reproductive processes; in zebrafish ovaries, PAQR8 expression increases during follicle maturation and responds to Nodal signaling to facilitate oocyte maturation 3. However, PAQR8 is dispensable for mammalian testis development, as knockout studies show normal sex determination despite its expression during this period, suggesting functional redundancy with related PAQR family members 4. Dysregulation of PAQR8 associates with pathological conditions: reduced expression in endometrial cancer correlates with unfavorable prognosis 5, while elevated PAQR8 in castration-resistant prostate cancer marks androgen receptor activation 6. PAQR8 expression is also downregulated in peripheral arteries following Western diet consumption, correlating with endothelial dysfunction 7, and altered in the ventral tegmental area during varicella zoster virus infection with age-dependent effects 8. Mendelian randomization analyses identify PAQR8 as a protective target for endometriosis treatment 9.